Your browser doesn't support javascript.
loading
Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.
Arismendi, Maria; Giraud, Matthieu; Ruzehaji, Nadira; Dieudé, Philippe; Koumakis, Eugenie; Ruiz, Barbara; Airo, Paolo; Cusi, Daniele; Matucci-Cerinic, Marco; Salvi, Erika; Cuomo, Giovanna; Hachulla, Eric; Diot, Elisabeth; Caramaschi, Paola; Riccieri, Valeria; Avouac, Jérôme; Kayser, Cristiane; Allanore, Yannick.
Afiliação
  • Arismendi M; Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France. arismendi.ma@gmail.com.
  • Giraud M; CAPES Foundation, Ministry of Education of Brazil, Brasília, DF, 70040-020, Brazil. arismendi.ma@gmail.com.
  • Ruzehaji N; Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France. matthieu.giraud@inserm.fr.
  • Dieudé P; Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France. nadira.ruzehaji@inserm.fr.
  • Koumakis E; Paris Diderot University, Rheumatology Department, Hôpital Bichat Claude Bernard, APHP, Paris, France. philippe.dieude@bch.aphp.fr.
  • Ruiz B; Paris Diderot University, INSERM U699, Hôpital Bichat Claude Bernard, Paris, France. philippe.dieude@bch.aphp.fr.
  • Airo P; Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France. koumakis@hotmail.com.
  • Cusi D; Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France. barbara.ruiz@inserm.fr.
  • Matucci-Cerinic M; Rheumatology and Clinical Immunology, Spedali Civili, Brescia, Italy. airo@bresciareumatologia.it.
  • Salvi E; University of Milano, Department of Medicine, Surgery and Dentistry San Paolo & Genomics and Bioinformatics Platform, Fondazione Filarete, Milan, Italy. daniele.cusi@unimi.it.
  • Cuomo G; Department of Biomedicine & Division of Rheumatology AOUC, Department of Rheumatology AVC, Department of Medicine & Denothe Centre, University of Florence, Florence, Italy. marco.matuccicerinic@unifi.it.
  • Hachulla E; University of Milano, Department of Medicine, Surgery and Dentistry San Paolo & Genomics and Bioinformatics Platform, Fondazione Filarete, Milan, Italy. salvi.erika@gmail.com.
  • Diot E; Department of Clinical and Experimental Medicine, Rheumatology Unit, Second University of Naples, Naples, Italy. giovanna.cuomo@unina2.it.
  • Caramaschi P; Université Lille II, Médecine Interne, Lille, France. eric.hachulla@chru-lille.fr.
  • Riccieri V; INSERM U618, IFR 135, CHU Bretonneau, Tours, France. ediot@med.univ-tours.fr.
  • Avouac J; Rheumatology Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy. paola.caramaschi@ospedaleuniverona.it.
  • Kayser C; Division of Rheumatology, Department of Medical Clinic and Therapy, University "Sapienza" of Rome, Rome, Italy. valeria.riccieri@uniroma1.it.
  • Allanore Y; Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France. jerome.avouac@cch.aphp.fr.
Arthritis Res Ther ; 17: 71, 2015 Mar 21.
Article em En | MEDLINE | ID: mdl-25880423

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / NF-kappa B / Interferon gama / Predisposição Genética para Doença / Peptídeos e Proteínas de Sinalização Intracelular / Fatores Reguladores de Interferon Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / NF-kappa B / Interferon gama / Predisposição Genética para Doença / Peptídeos e Proteínas de Sinalização Intracelular / Fatores Reguladores de Interferon Idioma: En Ano de publicação: 2015 Tipo de documento: Article